- Home
- RMBS vs CORT Comparison
RMBS vs CORT Comparison
Compare RMBS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBS
- CORT
- Stock Information
- Founded
- RMBS 1990
- CORT 1998
- Country
- RMBS United States
- CORT United States
- Employees
- RMBS N/A
- CORT N/A
- Industry
- RMBS Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- RMBS Technology
- CORT Health Care
- Exchange
- RMBS Nasdaq
- CORT Nasdaq
- Market Cap
- RMBS 4.7B
- CORT 4.0B
- IPO Year
- RMBS 1997
- CORT N/A
- Fundamental
- Price
- RMBS $51.31
- CORT $51.83
- Analyst Decision
- RMBS Strong Buy
- CORT Strong Buy
- Analyst Count
- RMBS 4
- CORT 4
- Target Price
- RMBS $74.00
- CORT $75.25
- AVG Volume (30 Days)
- RMBS 1.3M
- CORT 1.2M
- Earning Date
- RMBS 10-28-2024
- CORT 10-30-2024
- Dividend Yield
- RMBS N/A
- CORT N/A
- EPS Growth
- RMBS N/A
- CORT 57.97
- EPS
- RMBS 1.61
- CORT 1.26
- Revenue
- RMBS $517,746,999.00
- CORT $628,555,000.00
- Revenue This Year
- RMBS $25.37
- CORT $46.29
- Revenue Next Year
- RMBS $20.54
- CORT $17.09
- P/E Ratio
- RMBS $31.90
- CORT $41.11
- Revenue Growth
- RMBS 12.25
- CORT 39.67
- 52 Week Low
- RMBS $37.42
- CORT $20.84
- 52 Week High
- RMBS $76.38
- CORT $61.66
- Technical
- Relative Strength Index (RSI)
- RMBS 55.81
- CORT 52.64
- Support Level
- RMBS $54.12
- CORT $42.01
- Resistance Level
- RMBS $56.82
- CORT $61.66
- Average True Range (ATR)
- RMBS 2.41
- CORT 3.27
- MACD
- RMBS 0.04
- CORT -0.03
- Stochastic Oscillator
- RMBS 49.11
- CORT 49.97
About RMBS Rambus Inc.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.